<rss version="2.0"><channel><title>DeviceSpace.com All News</title><link>http://www.devicespace.com/</link><generator>DeviceSpace RSS Generator</generator><lastBuildDate>Sat, 07 Nov 2009 04:51:24 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/deviceSpaceLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=2</link></image>L<copyright>Copyright (C) 2009</copyright><item><title>Exiqon A/S To Acquire Oncotech  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78538&amp;full=1</link><description>Exiqon A/S and Oncotech Inc today announce that they have entered into a binding Letter of Intent under which Exiqon will acquire Oncotech, a California based leading supplier of extreme drug resistance diagnostic tests in cancer. The transaction will create a world leader in molecular diagnostic products based on miRNA. The consideration amounts to approximately USD 45 million (approximately DKK ...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Smith &amp; Nephew plc  Says Recalling Some Knee Implants  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78505&amp;full=1</link><description>London, UK--(Marketwire - November 27, 2007) - Smith &amp; Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business,announced today a precautionary recall of knees from the TC-PLUS*, VKS* andRT-PLUS* knee ranges. Smith &amp; Nephew has been informed by a UK supplier that alimited number of semi-finished knee implant castings have a higher thanspecified iron content.  These castings...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Mobile Phones Helping Doctors Diagnose Kids  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78480&amp;full=1</link><description>The mobile phone is increasingly being used by doctors to help them in the diagnosis of illness. It is particularly useful in the case of children, whose parents can record their symptoms and then show them to a paediatrician.Professor Denis Gill of Temple St children's hospital, Dublin, said he has already found static and video images of children, taken by parents, to be a useful diagnostic aid...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>"Super" Scanner Shows Key Detail  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78494&amp;full=1</link><description>A new scanner has been unveiled which can produce 3D body images of unprecedented clarity while reducing radiation by as much as 80%.  The new 256-slice CT machine takes large numbers of X-ray pictures, and combines them using computer technology to produce the final detailed images. </description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Mass Screening Ovarian Cancer Diagnostic Would Boost Survival Rates, UK  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78481&amp;full=1</link><description>HealthLinx Limited (ASX:HTX), has reached an agreement with The University of Liverpool (UK) to in-license additional patented biomarker technology and antibodies that has shown efficacy in detecting grade I &amp; II ovarian cancer.HealthLinx and The University of Liverpool (UK) have been jointly developing this technology over the past twelve months which has potential to be the world's first commercially...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Greatbatch, Inc. Signs Definitive Agreement to Acquire  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78491&amp;full=1</link><description>CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc. (NYSE: GB) announced today that it is has signed a definitive agreement to acquire Precimed, a leading technology-driven supplier to the orthopedic industry. This agreement also includes Precimeds contract to acquire the operations of another company in the orthopedic industry. The combined transaction will establish Greatbatch as one of the top three...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>What are the Benefits and Risks of Fitting Patients with Radiofrequency Identification Devices?  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78490&amp;full=1</link><description>In 2004, the United States Food and Drug Administration approved a radiofrequency identification (RFID) device that is implanted under the skin of the upper arm of patients and that stores the patients medical identifier. A debate in this week's PLoS Medicine discusses the pros and cons of patients getting fitted with such an RFID chip.When a scanner is passed over the RFID device, the identifier...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>biospace med Raises $18 Million in Venture Capital Funding  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78492&amp;full=1</link><description>PARIS &amp; ATLANTA--(BUSINESS WIRE)--biospace med, the orthopaedic imaging company, announced today the closing of $18 million (12 m) in venture capital financing led by NBGI Ventures (London) and Crdit Agricole Private Equity (Paris). Edmond de Rothschild Investment Partners (Paris) and UFG PE (Paris), current investors in the company, also have subscribed to the current round of financing. Aelios...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>More Faults in Halted Medtronic, Inc. Device?  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78499&amp;full=1</link><description>Despite tactful handling of its Fidelis lead recall, Medtronic (MDT - Cramer's Take - Stockpickr - Rating) may have more problems on the horizon with the insulated defibrillation wires, according to a Deutsche Bank research report late last week.</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>HistoRx, Inc.  Names CEO; Announces Board Changes - New Appointments Support Transition to Diagnostic Product Development Business  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78506&amp;full=1</link><description>&lt;p&gt;    NEW HAVEN, Conn., Nov. 27 /PRNewswire/ -- HistoRx, Inc., announced today that its Board of Directors has appointed Rana K. Gupta permanent Chief Executive Officer. Mr. Gupta has served as interim CEO since August 2006. During that time, the company advanced its proprietary AQUA(R) tissue biomarker analysis technology platform, increased its revenue stream to fund product development, and completed...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Novel MRI Technique Shows Secondhand Smoke Damages Lungs  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78487&amp;full=1</link><description>CHICAGO - For the first time, researchers have identified structural damage to the lungs caused by secondhand cigarette smoke.The results of the study, conducted by researchers at the University of Virginia School of Medicine in Charlottesville and The Children's Hospital of Philadelphia in Pennsylvania, were presented today at the annual meeting of the Radiological Society of North America (RSNA...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Natus Medical Incorporated Resumes Operations at Seattle Unit  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78504&amp;full=1</link><description>SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced that it has resumed all production and shipping operations at its Olympic Medical manufacturing facility in Seattle, Washington.On October 15, 2007, Natus received a warning letter from the Food &amp; Drug Administration ("FDA") related to the Olympic facility. The FDA letter focused on process deficiencies...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Toshiba America Medical Systems' AquilionONE Receives FDA Clearance  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78502&amp;full=1</link><description>CHICAGO--(BUSINESS WIRE)--Toshiba America Medical Systems, Inc., a leader in diagnostic and medical imaging, today announced FDA clearance of the most advanced diagnostic imaging computed tomography (CT) equipment available  the AquilionONE. With this clearance, Toshiba is on schedule to make the system commercially available in summer, 2008. AquilionONE, the worlds first dynamic volume CT system...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Visage Imaging and Medicsight Announce Collaboration to Provide Thin Client- Based CT Colonography Solution Visage Imaging to Integrate Medicsight's CT Colonography and ColonCAD Technologies into the Visage(TM) Thin Client PACS solutions  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78507&amp;full=1</link><description>&lt;p&gt;    CARLSBAD, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Visage Imaging, Inc., a wholly owned subsidiary of Mercury Computer Systems, Inc. , and Medicsight announced a partnership on the joint development of an advanced CT colonography solution which will be fully integrated with the Visage(TM) Thin Client/Server platform.&lt;/p&gt;&lt;p&gt;    "We look forward to supporting Visage Imaging in delivering this...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78530&amp;full=1</link><description>&lt;p&gt;    IRVINE, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry, today announced approval of the Masimo Rad-57 Pulse CO-Oximeter, bringing the world's first and only technology capable of noninvasively measuring carbon monoxide (CO) levels in the blood to the Japanese market -- with 9,026 hospitals and Fire...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Cook Medical Delivers Innovative Treatment for Recto-Vaginal Fistulas  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78579&amp;full=1</link><description>SPENCER, Ind.--(BUSINESS WIRE)--Cook Medical, one of the worlds largest private medical device companies, announced today a major step forward in the treatment of recto-vaginal fistulas, abnormal tracts that form between a womens rectum and vagina. The Surgisis Biodesign Recto-Vaginal Fistula Plug communicates with the patients body, signaling surrounding tissue to grow across the plug and allowing...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Thinnovation at RSNA 2007: Visage Imaging to Showcase Award-Winning Thin Client PACS Solutions  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78381&amp;full=1</link><description>CARLSBAD, Calif.--(BUSINESS WIRE)--Visage Imaging, a wholly owned subsidiary of Mercury Computer Systems, Inc. (NASDAQ: MRCY), will showcase its Visage product line for enterprise-wide image management and advanced visualization at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago, Illinois, November 25-30.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;NEC Display Solutions&lt;/b&gt; Offers New MultiSync 5-Megapixel Grayscale Display for Medical Professionals  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78471&amp;full=1</link><description>CHICAGO--(BUSINESS WIRE)--NEC Display Solutions of America, a leading stand-alone provider of commercial and residential LCD, plasma, and projector displays, announced today availability of the MultiSync MD21GS-5MP flat-panel monitor, specifically for medical imaging applications, including mammography and PACS (picture archiving and communication system).</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>ReBuilder Medical Technologies, Inc. Announces Record Sales Month  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78385&amp;full=1</link><description>&lt;p&gt; MRSA fears increasing public awareness of Molluscum Contagiosum&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;CHARLES TOWN, W.V., Nov 26 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc.  a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum today announced record breaking sales for the month of October 2007; increase is 12% above previous record which was set in September 2007.&lt;/p...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Terarecon, Inc. Appoints New President  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78464&amp;full=1</link><description>TeraRecon (www.terarecon.com), a leader in innovative imaging processing technology and advanced 3D visualization solutions, today announced that its board of directors has appointed Robert James Taylor, Ph.D. as president, effective November 25th, 2007. Dr. Taylor will also continue to serve as the company's chief operating officer. Motoaki Saito, M.D., Ph.D., who has served as president and chief...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Endocare, Inc. Announces That National Cancer Institute to Sponsor Study Comparing Cryoablation to Radiation Therapy  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78531&amp;full=1</link><description>&lt;p&gt;    IRVINE, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Endocare, Inc. , an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologists for tissue and tumor ablation, announced today that the National Cancer Institute (NCI) of the National Institutes of Health (NIH) is supporting a multi-center study comparing the...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>HepaLife Technologies Inc. Enters Into New Cooperative Research and Development Agreement with U.S. Government Agency  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78575&amp;full=1</link><description>BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced that the Company has entered into a new Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Agriculture, Agricultural Research Service (USDA, ARS) for further optimization of HepaLifes PICM-19 liver stem cell line for application in the first-of-its-kind bioartificial...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>&lt;B&gt;StudioNorth&lt;/b&gt; Signs Agency of Record Agreement with Landauer  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78572&amp;full=1</link><description>NORTH CHICAGO, Ill.--(BUSINESS WIRE)--StudioNorth announced today that it has been selected as agency of record by Landauer Inc., the world leader in radiation monitoring products and services. Under the agreement, StudioNorth will revitalize the Landauer brand to reflect the companys forward-thinking goals and future market opportunities  for implementation across the full spectrum of marketing...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Cambridge Research &amp; Instrumentation, Inc. Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78536&amp;full=1</link><description>&lt;p&gt;    WOBURN, Mass., Nov. 26 /PRNewswire/ -- Cambridge Research &amp; Instrumentation, Inc. (CRi) announces the launch of Maestro 2 optical imaging systems in North America. The Maestro 2 received widespread acclaim at the both the recent Society of Molecular Imaging/Academy of Molecular Imaging joint conference for in vivo imaging, and at the Stanford University Small Animal Imaging Workshop as well...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Siemens Medical Solutions Unveils New Digital Mammography System for Optimized Screening New MAMMOMAT(R) Novation S Introduces Innovations to Accelerate Workflow  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78539&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 27 /PRNewswire-FirstCall/ -- Siemens Medical Solutions (www.usa.siemens.com/medical) introduces the MAMMOMAT(R) Novation S, a new digital mammography system designed to optimize clinical workflow for screenings, at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 25 to 30 at McCormick Place (Booth #7713, Hall B).&lt;/p...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Accuray Inc. Shanghai's First CyberKnife(R) System Installed at Major Academic Oncology Center Install Marks the Fifth System in China and 121st CyberKnife System Installation  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78554&amp;full=1</link><description>&lt;p&gt;    SUNNYVALE, Calif, Nov. 27 /PRNewswire-FirstCall/ -- Accuray Incorporated , a global leader in the field of radiosurgery, announced today that Hua Shan Hospital in Shanghai has installed a CyberKnife(R) Robotic Radiosurgery System for its Pudong District facility. The installation marks the first CyberKnife System in Shanghai and the fifth System in China, providing greater patient access to...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Fifty Hospitals Around the World Are Now Using NeuroLogica's CereTom(R) Portable CT Scanner  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78580&amp;full=1</link><description>DANVERS, Mass. &amp; CHICAGO--(BUSINESS WIRE)--NeuroLogica Corporation today announced that The Moses H. Cone Memorial Hospital in Greensboro, N.C. is the 50th hospital to purchase its CereTom portable CT scanner. NeuroLogica has seen widespread adoption of its portable CT technology that enables physicians to obtain high-quality CT images without the need to transport patients to the traditional hospital...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>StatSure Diagnostic Systems, Inc. Awarded Patents in Japan and India  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78548&amp;full=1</link><description>&lt;p&gt;    FRAMINGHAM, Mass., Nov. 27 /PRNewswire-FirstCall/ -- StatSure Diagnostic Systems, Inc.  announced the issuance in Japan and in India of additional international patents for its diagnostic testing platform, termed the "barrel" technology. StatSure's technology is also protected by a US patent and is part of a licensed, FDA approved and CLIA waived product for HIV, currently being sold in the...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Aethlon Medical Files Cancer Diagnostic Patent  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78598&amp;full=1</link><description>SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, disclosed today it has filed a provisional patent entitled, Affinity Capture of Circulating Cancer Biomarkers, with the U.S. Patent and Trademark Office (USPTO). The patent describes the use of the Aethlon Hemopurifier as a device that fills the unmet need of identifying...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Evalve, Inc. Completes $60 Million Series D Financing Financing  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78542&amp;full=1</link><description>&lt;p&gt;    MENLO PARK, Calif., Nov. 27 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that it had successfully completed a $60 million Series D financing.  BBT Fund LP led the round and was joined by current Evalve investors including, Delphi Ventures, New Enterprise Associates, Split Rock Partners and Abbott Laboratories...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>IRIS International, Inc. Files Shelf Registration Statement  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78500&amp;full=1</link><description>CHATSWORTH, Calif.--(BUSINESS WIRE)--IRIS INTERNATIONAL, INC. (NASDAQ GM: IRIS), a leading developer, manufacturer and marketer of medical devices, diagnostic systems and consumables, today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) which, when declared effective by the SEC, will allow IRIS from time to time to offer and...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>AspenBio Pharma, Inc. Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78543&amp;full=1</link><description>&lt;p&gt;    CASTLE ROCK, Colo., Nov. 27 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc.  an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, has received an official response from the Food and Drug Administration (FDA) Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD) regarding AspenBio's pre-investigational device exemption...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Abbott&lt;/b&gt; to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to Abbott Diagnostics Advisory Committee  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78544&amp;full=1</link><description>&lt;p&gt;    ABBOTT PARK, Ill., Nov. 27 /PRNewswire-FirstCall/ -- Abbott today released a summary of clinical highlights on the XIENCE(TM) V Everolimus Eluting Coronary Stent System, which will be presented Nov. 29 to the Circulatory System Devices Advisory Panel, an advisory committee to the U.S. Food and Drug Administration (FDA). The clinical summary was released in conjunction with the posting of the...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Xceed Molecular Launches Strategic Collaborator Program  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78541&amp;full=1</link><description>&lt;p&gt;    WELLESLEY, Mass., Nov. 27 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that the company has launched its Strategic Collaborator program and signed its first member, the Center for Molecular Medicine (CMM), of Grand Rapids, Michigan. Specific terms were not disclosed.&lt;/p&gt;&lt;p&gt;    According to Xceed's President...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>SpinalMotion Closes $14 Million Loan Facility With GE Healthcare Financial Services  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78566&amp;full=1</link><description>MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SpinalMotion, developer of two investigational artificial discs for treating patients with degenerative disc disease, has closed a $14 million loan facility with GE Healthcare Financial Services. The venture debt will be used to fund SpinalMotions product expansion and additional clinical evaluation.</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>SV Life Sciences Adds Medical Device Executive to MedTech Team  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78393&amp;full=1</link><description>BOSTON &amp; SAN FRANCISCO--(BUSINESS WIRE)--SV Life Sciences Advisers, LLC (SVLS) today announced that Robert J. Palmisano has joined the firm as a venture partner. Mr. Palmisano was most recently Chief Executive Officer and Director of IntraLase (Nasdaq:ILSE), which was acquired by Advanced Medical Optics (NYSE:EYE) earlier this year in a transaction totaling over $800 million.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Zecotek Photonics Inc. Announces Appointments to Scientific Advisory Board  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78479&amp;full=1</link><description>VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 26, 2007) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I), formerly Zecotek Medical Systems Inc., today announced it has appointed Dr. K.A. Abraham and Dr. Teoh Tiong Ann to its Advisory Board.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Cook Biotech Incorporated To Be Featured on History Channel's Modern Marvels  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78442&amp;full=1</link><description>WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Cook Biotech Incorporated will be featured on the History Channels Modern Marvels series scheduled to air tomorrow, Tuesday, November 27th, at 8 p.m. EST. The show features Cooks revolutionary technology, Surgisis Biodesign, which represents an entirely new category in the evolution of tissue repair.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Precision Optics Corporation Announces First Quarter Results  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78236&amp;full=1</link><description>&lt;p&gt;    GARDNER, Mass., Nov. 20 /PRNewswire-FirstCall/ -- Precision Optics Corporation, Inc. , (the "Company") today announced operating results on an unaudited basis for the first quarter of fiscal year 2008 ended September 30, 2007.&lt;/p&gt;&lt;p&gt;    First Quarter Operating Results&lt;/p&gt;&lt;p&gt;    Revenues -- Total revenues for the quarter ended September 30, 2007 were $1,101,728, an increase of $674,103 or 1...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>EDAP TMS S.A. 2007 Third Quarter HIFU Revenues Increase  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78590&amp;full=1</link><description>LYON, France, Nov. 26, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (NasdaqGM:EDAP - News), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a wide portfolio of minimally invasive medical devices primarily for the treatment of urological diseases today reported financial results for...</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Bio-Imaging Technologies, Inc. to Present at  ''Focus on Healthcare Conference'' December 4, 2007 in New York City  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78588&amp;full=1</link><description>NEWTOWN, Pa.--(BUSINESS WIRE)--Bio-Imaging Technologies, Inc. (Bio-Imaging) (NASDAQ: BITI) today announced that it is scheduled to present at BMO Capital Markets Focus on Healthcare Conference, on Tuesday, December 4, 2007 at 1:30 PM Eastern Time. The conference will run December 4 and 5 at the Millennium Broadway Hotel in New York City.</description><pubDate>Tue, 27 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Pressure Sensor with Diagnostic Function for Pumps  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78331&amp;full=1</link><description>To do so, it permanently evaluates the dynamic pressure fluctuations in the system and compares them to the reference values stored by teaching. Damage, e.g by cavitation or trapped air, is detected at an early stage. So, the sensor can be perfectly integrated in condition-based maintenance concepts.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Massive Necrosis after Trans-Catheter Treatment is More Common in the Presence of Tumor Capsule  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78312&amp;full=1</link><description>Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Prognosis of patients with HCC complicating cirrhosis mainly depends on the tumor growth, progression of the underlying liver disease and the effectiveness of antitumoral treatment. Trans-catheter treatment is extensively used to treat HCC not suitable for surgical resection or percutaneous ablation therapies. Unfortunately...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Massachusetts Institute of Technology (MIT): Prenatal Arsenic Exposure Detected in Newborns; Research Could Lead to Test for Screening Populations for the Poison  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78314&amp;full=1</link><description>CAMBRIDGE, Mass  MIT researchers have found that the children of mothers whose water supplies were contaminated with arsenic during their pregnancies harbored gene expression changes that may lead to cancer and other diseases later in life. In addition to establishing the potential harmful effects of these prenatal exposures, the new study also provides a possible method for screening populations...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Brain Scans 'May Detect OCD Risk'  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78317&amp;full=1</link><description>Brain scans may be able to reveal which people are at genetic risk of developing obsessive compulsive disorder (OCD), researchers say.Individuals with OCD and their close relatives have distinctive patterns in their brain structure, a team at Cambridge University found. </description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Inverness Medical Innovations, Inc. Agrees to Acquire  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78325&amp;full=1</link><description>&lt;p&gt;    WALTHAM, Mass., Nov. 26 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc.  today announced that it has entered into a definitive agreement to acquire ParadigmHealth, Inc.   ParadigmHealth, headquartered in New Jersey, is a leading provider and integrator of care and disease management services for acutely ill and clinically complex patients, including neonatal intensive care and...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;HealthpointCapital&lt;/b&gt; to Acquire &lt;b&gt;Ideal Medical Products&lt;/b&gt;  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78330&amp;full=1</link><description>&lt;p&gt;    PARIS, Nov. 21 /PRNewswire/ -- HealthpointCapital Partners II, L.P., a private equity fund that specializes in orthopedic medical devices, announced today that, through its Healthpoint (Luxco) II S.a.r.l. subsidiary, it has acquired Paris-based Ideal Medical Products, S.A. Ideal Medical Products is the principal shareholder and will remain principal shareholder of leading spinal implant developer...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Amedica Corporation Receives FDA 510(k) Clearance for Valeo(TM) Pedicle Screw System  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78359&amp;full=1</link><description>&lt;p&gt;    SALT LAKE CITY, Nov. 26 /PRNewswire/ -- Amedica Corporation, an orthopedic implants company focused on silicon nitride ceramic technologies, announced today that the U.S. Food and Drug Administration has granted 510(k) marketing clearance to Amedica's Valeo(TM) Pedicle Screw system.&lt;/p&gt;&lt;p&gt;    The Valeo Pedicle Screw system is a low profile and modular pedicle screw system incorporating features...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>New Medical Device Profile for Bluetooth Wireless Technology  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78323&amp;full=1</link><description>The Bluetooth Special Interest Group (SIG) announced a Medical Device Profile for Bluetooth wireless technology at Medica in Dsseldorf last week.A Bluetooth profile defines how different applications use Bluetooth wireless technology to set up a connection and exchange data. The Medical Devices Working Group of the Bluetooth SIG developed this profile to ensure that devices in the medical environment...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Carbylan BioSurgery, Inc.&lt;/b&gt; Announces $20 Million Series B Financing  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78327&amp;full=1</link><description>PALO ALTO--(BUSINESS WIRE)--Carbylan BioSurgery, Inc., a medical device company focused on development of bioresponsive medical products for osteoarthritis and chronic rhinosinusitis, today announced the closing of a $20 million Series B preferred stock financing. The financing was led by Vivo Ventures and included existing investors Alta Partners and InterWest Partners. In connection with the financing...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Diamyd Medical AB: Executes Agreement with US National Institutes of Health (NIH) for a Type 1 Diabetes Trial with the Experimental Diamyd(R) Diabetes Vaccine  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78329&amp;full=1</link><description>STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:Diamyd Medical AB (www.omxgroup.com, ticker: DIAM B; www.otcqx.com, ticker DMYDY)Diamyd Medical (NASDAQ:DMYDY) (STO:DIAMB) announced today that it has executed a Clinical Trial Agreement with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for a planned clinical study with the Diamyd GAD-alum diabetes vaccine...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>DiaMedica Inc. Announces Formation of European Subsidiary  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78477&amp;full=1</link><description>WINNIPEG, MANITOBA--(Marketwire - November 22, 2007) - DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and development company focused on novel treatments for type 2 diabetes today announces the formation of DiaMedica Europe Ltd. in the United Kingdom. DiaMedica Europe Ltd. was formed to facilitate the performance of clinical studies in the European Union and is a wholly owned subsidiary of DiaMedica...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Obesity 'May Distort Cancer Test'  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78318&amp;full=1</link><description>Doctors must take body weight into account when reading test results for prostate cancer as obesity may distort the findings, a US study argues.Obese men have more blood so the concentration of antigen, a marker for the disease, is lower, a team found. </description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>FDA Approves St. Jude Medical Tissue Heart Valve  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78332&amp;full=1</link><description>ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval of its Epic Stented Tissue Valve with Linx AC Technology. Identical in design to the companys Biocor Valve, which currently leads the tissue valve industry in U.S. market share growth, the Epic Valve also incorporates patented anti-calcification technology designed...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Immunicon Corporation  : CellSearch(TM) Circulating Tumor Cell Kit Receives FDA Clearance for Monitoring Patients with Metastatic Colorectal Cancer  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78326&amp;full=1</link><description>HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ-GM:IMMC) announced today that FDA clearance has been received for the CellSearch Circulating Tumor Cell Kit as an aid in the monitoring of patients with metastatic colorectal cancer. The CellSearch test was originally cleared in 2004 for in vitro diagnostic use in patients with metastatic breast cancer. Serial testing for circulating...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Signalife, Inc. Receives FDA Clearance for OTC Non-Prescription Event Recorder Device  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78347&amp;full=1</link><description>&lt;p&gt;    LOS ANGELES, Nov. 26 /PRNewswire-FirstCall/ -- Signalife, Inc.  has received FDA 510(k) clearance to market and sell - without prescription - its ambulatory event recorder throughout the United States. This device, which Signalife will market as the Fidelity 200 HeartLife Tempo Card, is a direct-to-consumer non-prescription flexible credit card- sized heart monitoring device which will be used...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Immucor Appoints New Chief Financial Officer  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78222&amp;full=1</link><description>&lt;p&gt;    NORCROSS, Ga., Nov. 20 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Richard A. Flynt has agreed to join Immucor as Vice President and Chief Financial Officer effective December 10, 2007.  The company previously announced that current CFO Patrick Waddy intended to resign for...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Mindray Medical to Attend 2007 RSNA Conference in Chicago  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78235&amp;full=1</link><description>&lt;p&gt;    SHENZHEN, China, Nov. 21 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited , a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that it will attend the 2007 Radiological Society of North America (RSNA) Conference in Chicago, Illinois at the McCormick Place from November 25 to 30, 200...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Popping Bubbles to Treat Cancer  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78030&amp;full=1</link><description>Scientists at the University of Oxford are trying to harness the energy released when bubbles burst as a way of killing off cancer cells.They have built a device to beam waves of ultrasound into the body, generating bubbles at the site of a tumour. </description><pubDate>Tue, 20 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Merit Medical Systems, Inc. Announces 510(k) Notification for Resolve Biliary Catheter  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78407&amp;full=1</link><description>SOUTH JORDAN, Utah, Nov. 26, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems Inc. (NasdaqGS:MMSI - News), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has received notification from the FDA of 510(k) clearance for the Resolve(tm) Biliary Catheter.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Meridian Bioscience, Inc. Receives FDA Clearance for Two New Rapid Tests for the Detection of Influenza and Respiratory Syncytial Virus  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78438&amp;full=1</link><description>CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market two new upper respiratory tests: TRU FLU and TRU RSV. These tests are based upon a new rapid test technology that features improved safety and space savings. TRU FLU detects both influenza A and influenza B while TRU RSV detects...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Alara, Inc. Receives FDA Clearance to Market CRystalView T-Series CR System  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78357&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 26 /PRNewswire/ -- MCCORMICK PLACE, HALL A, BOOTH #3382 -- Alara Inc., a leading manufacturer of Computed Radiography (CR) medical imaging products, today announced it is showcasing the CRystalView T-Series desktop CR system at RSNA 2007 in Chicago. Alara, Inc. has received US Food and Drug Administration clearance to market the CRystalView T-Series CR system, and the system is...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>China Blacklists Unqualified Medical Devices  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78322&amp;full=1</link><description>  BEIJING, Nov. 21 (Xinhua) -- China's State Food and Drug Administration (SFDA) has warned 13 companies about manufacturing unapproved medical devices, which have been blacklisted in a new round of spot checks.    Eighty percent of the photonic cosmetic machines (similar to lasers) from five companies and about 43 percent of high frequency electric knives (which can be used in dental procedures...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>GE Healthcare Says CT Scan Has Clearer Images, Cuts Radiation  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78328&amp;full=1</link><description>CHICAGO--(BUSINESS WIRE)--High-Definition (HD) technology is coming into every facet of our lives. Its used in the electronics in our homes, the radios in our cars and may be coming soon to the health care providers we depend on.At a media conference at the 2007 meeting of the Radiological Society of North America (RSNA) in Chicago, GE Healthcare, a unit of General Electric (NYSE: GE), showcased...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Corgenix Medical Corporation Releases Clinical Trial Data on AtherOxTM  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78473&amp;full=1</link><description>DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB:CONX), a worldwide developer and marketer of diagnostic test kits, has announced promising results from a preliminary clinical trial involving its AtherOxTM test kit. The study was sponsored by Corgenix and Medical &amp; Biological Laboratories, Ltd.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Oncologix Tech, Inc.  Provides Guidance on Oncosphere Project Milestones and Timeline  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78476&amp;full=1</link><description>SUWANEE, GA--(Marketwire - November 26, 2007) - Oncologix Tech Inc. (OTCBB: OCLG) announced today that it completed animal studies with rabbits, fulfilling four of the six objectives needed for the FDA IDE submission and will need to test the Oncosphere with another animal model to demonstrate the final two objectives. Additionally, Oncologix Tech announced that it intends to apply for ISO certification...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>China Medical Technologies, Inc. Announces Acquisition of a Fast-Growing ECLIA Player to Strengthen its Leading Position in Advanced IVD Market in China  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78355&amp;full=1</link><description>&lt;p&gt;    BEIJING, Nov. 26 /Xinhua-PRNewswire/ -- China Medical Technologies, Inc. (the "Company") , a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products and high intensity focused ultrasound tumor therapy system, today announces that it has entered into a definitive acquisition agreement to purchase the entire equity interest...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Vital Images, Inc. Announces Worldwide, Including Japan, Distribution and Licensing Agreement With Toshiba Medical Systems Corporation (Japan)  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78371&amp;full=1</link><description>&lt;p&gt;    MINNEAPOLIS, Nov. 26 /PRNewswire-FirstCall/ -- Vital Images, Inc. , a leading provider of enterprise-wide advanced visualization and analysis solutions, announced a worldwide distribution and licensing agreement with Toshiba Medical Systems Corporation providing advanced visualization and analysis solutions for Toshiba's newly launched AquilionONE(TM) dynamic volume CT scanner. The announcement...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>The Italian and Salt Lake City, Utah-based TechniScan Medical Systems Sign Key Technology Sharing and Financial Partnership Agreement  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78439&amp;full=1</link><description>GENOA, Italy &amp; SALT LAKE CITY--(BUSINESS WIRE)--The Esaote Group (Esaote), an international leader in the production of medical imaging and diagnostic technologies, and TechniScan Medical Systems (TMS) Inc., a Salt Lake City-based developer of ultrasound technology for breast imaging, have signed an important partnership agreement to share technologies and intellectual property, collaborate in the...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Visage Imaging and Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78474&amp;full=1</link><description>CARLSBAD, Calif.--(BUSINESS WIRE)--Visage Imaging, a wholly owned subsidiary of Mercury Computer Systems, Inc. (NASDAQ: MRCY), announced a worldwide integration agreement with Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, based in Belgium.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Oncology Med&lt;/b&gt; Signs Multi-Year Contract With &lt;b&gt;Meadville Medical Center&lt;/b&gt;'s New Comprehensive Cancer Treatment Facility  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78475&amp;full=1</link><description>PITTSBURGH, PA--(Marketwire - November 26, 2007) - Oncology Med, Inc. (PINKSHEETS: ONCO), a Pittsburgh-based cancer treatment solutions group, announced today that it has signed a new multi-year exclusive contract with the Meadville Medical Center in Meadville, Pennsylvania providing Meadville's state-of-the-art, full-service cancer treatment center with a full range of medical physics support to include...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Siemens Medical Solutions Unveils an Unprecedented Number of Leading-Edge Solutions  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78338&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 25 /PRNewswire/ -- This week, the more than 25,000 healthcare professionals expected to attend the world's largest annual medical meeting -- the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) -- will learn how Siemens Medical Solutions (www.siemens.com/medical) is innovating every step of its customers' workflow. Siemens will showcase...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>E-Rad Solutions Selects Compressus Inc.'s Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78340&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 26 /PRNewswire/ -- RSNA Booth #5924 -- Compressus Inc., makers of the MEDxConnect(TM) technology for seamless connectivity and interoperability between diagnostic acquisition devices, PACS, HIS, RIS, and related information systems, announced today that E-Rad Solutions of Palm Beach Gardens, Fla., has selected the MEDxConnect System to fuel its entry into the teleradiology market...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>ZONARE Medical Systems, Inc. Surpasses 1000th Worldwide z.one Ultrasound System Shipment  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78343&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 26 /PRNewswire/ -- ZONARE Medical Systems, a developer of premium ultrasound systems, announced at the Radiology Society of North America (RSNA) Annual Congress, being held November 25 - 30, 2007, it has recently shipped the company's 1,000th Convertible Ultrasound(TM) platform to the German Cancer Research Center. The Center is one of the most respected cancer research facilities...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Siemens Medical Solutions Introduces Its New Generation of Artis Interventional Imaging Systems  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78364&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 25 /PRNewswire-FirstCall/ -- Siemens Medical Solutions (www.usa.siemens.com/medical) introduces its next generation of interventional imaging systems that offer breakthrough versatility, enhanced image quality and streamline workflow across an array of clinical environments, from body and neurointerventional radiology suites to operating rooms and hybrid rooms. Siemens is showcasing...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Bradley Pharmaceuticals Launches ROSULA(R) CLK(TM)  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78367&amp;full=1</link><description>&lt;p&gt;    FAIRFIELD, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc.  today announced that its Doak Dermatologics subsidiary has launched ROSULA(R) CLK(TM), a kit combining two topical skincare products currently marketed by Doak. The kit contains ROSULA(R) Clarifying Wash(TM) (Sodium Sulfacetamide 10% and Sulfur 4%) in a urea vehicle, and A-FIL(R) Cream (meradimate 5% and titanium...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Siemens' New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78373&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 26 /PRNewswire/ -- At the 93rd Scientific Sessions and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 25 to 30 at McCormick Place (Booth 7713, Hall B), Siemens Medical Solutions (www.usa.siemens.com/medical) will unveil the ACUSON S2000(TM) ultrasound platform, the first system in Siemens' new S Class of ultrasound products. It will have capabilities...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Siemens Medical Solutions Showcases Its Most Comprehensive and Advanced Breast Care Portfolio Seek-Find-Act-Follow  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78383&amp;full=1</link><description>&lt;p&gt;    CHICAGO, Nov. 25 /PRNewswire-FirstCall/ -- Siemens Medical Solutions (www.usa.siemens.com/medical) introduces the latest innovations to its breast care portfolio, designed to help detect, diagnose and treat breast cancer earlier, faster, and with greater precision, at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 25 to 30 at McCormick...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78399&amp;full=1</link><description>O'FALLON, Mo.--(BUSINESS WIRE)--Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will begin producing a lower priced, electrosurgical generator with full feature cut and coagulation modes. The new unit, designed to fill the price range between the small coagulation only unit, COAG, and the up-market AdvantageTM, named Dual WaveTM is designed to address cost compression in the marketplace...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>SenoRx, Inc. Announces Launch of Its VisiLoc MRI Visible Obturator At the Annual Meeting of the Radiological Society of North America (RSNA)  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78405&amp;full=1</link><description>ALISO VIEJO, Calif., Nov. 26, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (NasdaqGM:SENO - News) today announced the launch of its VisiLoc(tm) MRI visible obturator, compatible with its EnCor(r) breast biopsy system, at the annual meeting of the Radiological Society of North America (RSNA) in Chicago. The product facilitates location of a lesion for breast biopsy under MRI image guidance.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Royal Philips Electronics N.V. Unveils Computed Tomography (CT) System That Scans the Heart in Two Beats to Aid in Diagnosis and Treatment of Serious Health Conditions  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78423&amp;full=1</link><description>CHICAGO--(BUSINESS WIRE)--Today, at the 93rd annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics (NYSE: PHG, AEX: PHI) unveiled its latest innovative healthcare products and technologies that seek to make a difference in how radiologists can prevent, diagnose, treat and monitor disease, and allow them to focus more on their patients.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Canon U.S.A., Inc. Showcases Its Line of Portable and Digital Radiography Solutions at in Chicago  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78424&amp;full=1</link><description>CHICAGO--(BUSINESS WIRE)--Canon U.S.A., Inc., will showcase the versatility and usability of its current line of advanced portable and general digital radiography (DR) systems and solutions at the 2007 Radiological Society of North America Annual Meeting (RSNA 2007), taking place at McCormick Place in the South Building - Hall A in booth # 3311 (November 25 - 29).</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Del Global Technologies Corp.: Launches New Apollo DRF at Radiological Society of North America (RSNA) 2007  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78469&amp;full=1</link><description>FRANKLIN PARK, Ill.--(BUSINESS WIRE)--Del Global Technologies Corp. (OTCBB: DGTC) ("Del Global" or "the Company") today announces the Apollo DRF, a full-featured, multi-functional table with dynamic flat panel detector that produces full-field, high resolution imaging for a broad range of radiographic and fluoroscopic examinations.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Del Global Technologies Corp.: Introduces the DEL Image Management System at Radiological Society of North America (RSNA) 2007  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78470&amp;full=1</link><description>FRANKLIN PARK, Ill.--(BUSINESS WIRE)--Del Global Technologies Corp. (OTCBB: DGTC) ("Del Global" or "the Company") today announces the DEL Image Management System (DEL IMS) DR acquisition system for use in a broad range of radiographic studies. The system is designed to deliver outstanding image quality, image consistency and improve diagnostic workflow in the exam room and throughout the radiographic...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>North American Scientific Inc. Announces Extension of Loan Agreements  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78431&amp;full=1</link><description>CHATSWORTH, Calif.--(BUSINESS WIRE)--North American Scientific, Inc. (Nasdaq:NASI) today announced that on November 20, 2007 it executed a Seventh Amendment and Forbearance to its Loan and Security Agreement with Silicon Valley Bank (the Bank). The Amendment includes: (i) an extension of the maturity date of the Loan Agreement to December 20, 2007, and an extension of the maturity date of the Bridge...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Pyng Medical Corp. to Release Audited Fiscal 2007 Results on November 28  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78461&amp;full=1</link><description>RICHMOND, BRITISH COLUMBIA--(Marketwire - November 26, 2007) - Pyng Medical Corporation (TSX VENTURE: PYT) will release its audited fiscal 2007 year end results on Wednesday, November 28, 2007. A news release summarizing the results will be distributed at 9 am EST/6 am PST; full audited financial results will be available on SEDAR at www.sedar.com. </description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Laboratory Corporation of America Holdings is Scheduled to Present at the Merrill Lynch Health Services Investor Conference  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78451&amp;full=1</link><description>BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America Holdings (LabCorp) (NYSE:LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T. Smith, Executive Vice President, Corporate Affairs, are scheduled to speak at the Merrill Lynch Health Services Investor Conference in New York, NY. LabCorps presentation is planned for...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>ART Advanced Research Technologies Inc. to be Present at the Annual Meeting of the Radiological Society of North America (RSNA) in Chicago  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78460&amp;full=1</link><description>MONTREAL, CANADA--(Marketwire - November 26, 2007) - ART Advanced Research Technologies Inc. ("ART")(TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce its participation at the 93rd annual meeting of the Radiological Society of North America (RSNA) being held at McCormick Place in Chicago...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>ZOLL Medical Corporation to Speak at the Piper Jaffray 19th Annual Health Care Conference  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78378&amp;full=1</link><description>CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that Richard A. Packer, its Chief Executive Officer, will speak at 12:00 p.m. on Tuesday, November 27, 2007 in New York City at the Piper Jaffray 19th Annual Health Care Conference being held at The Pierre New York, Fifth Avenue at 61st...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>NeuroMetrix, Inc. to Present at the Piper Jaffray Health Care Conference  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78472&amp;full=1</link><description>WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company advancing patient care through the development and marketing of innovative products used to diagnose and treat diseases of the nervous system, neurovascular disorders, and pain, announced today that it is scheduled to present at the Piper Jaffray Health Care Conference at The Pierre Hotel in New York City at...</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Third Wave Technologies, Inc. to Present at Piper Jaffray Health Care Conference  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78478&amp;full=1</link><description>MADISON, Wis.--(BUSINESS WIRE)--Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that it will present at the Piper Jaffray Health Care Conference, which is being held Nov. 27-29, at the Pierre Hotel in New York. Kevin T. Conroy, Third Wave's president and chief executive, will make the companys presentation on Tuesday, Nov. 27, 2007, at 12 p.m. EST.</description><pubDate>Mon, 26 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>MIV Therapeutics Inc. to Sell Israeli Subsidiary  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78288&amp;full=1</link><description>MIV Therapeutics, Inc. (OTCBB: MIVT) (FRANKFURT: MIV), a leading developer of next-generation coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, made public that it has entered into a definitive Share Purchase Agreement to sell all of its issued and outstanding shares of SagaX Inc. ("SagaX") in consideration of the repayment of $4.0 million...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Post-Treatment PET Scans Can Reassure Cervical Cancer Patients, Washington University in St. Louis Study  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78192&amp;full=1</link><description>Nov. 20, 2007 -- Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Spread of Illegal Devices Causes Alarm  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78207&amp;full=1</link><description>U.S. Rep. Jay Inslee on Tuesday called for a congressional investigation into medical-device manufacturers and operators who use unproven "energy medicine" machines to exploit patients."I fear these may be the tip of the iceberg when it comes to deadly scams aimed at vulnerable Americans who are sick and holding out hope for a cure to what ails them," Inslee, D-Bainbridge Island, said in a letter...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Pedometers Help People Stay Active, Stanford University School of Medicine Study Finds  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78190&amp;full=1</link><description>STANFORD, Calif.  The pedometer, a small, inexpensive device that counts the number of steps walked per day, could be key to ramping up a persons physical activity.Researchers at the Stanford University School of Medicine have found that the use of a pedometer is associated with significant increases in physical activity and weight loss and improvements in blood pressure.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>CT Colonography Detects Wide-Range of Extracolonic Abnormalities in Elderly Patients  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78197&amp;full=1</link><description>CT colonography (CTC), when used in elderly patients, can detect a high number of new and significant abnormalities outside the colon (including cirrhosis and tumors) and is well tolerated, according to a recent study conducted by researchers at St. Jamess University Hospital in Leeds, United Kingdom (UK).</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Insulin Patch Co. Raises $27M  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78208&amp;full=1</link><description>Medical device start-up Medingo Ltd. has raised $27 million from its parent company, Elron Electronic Industries Ltd. (Nasdaq: ELRN; TASE: ELRN) and US venture capital fund Radius Ventures. Elron will invest between $13 million and $22 million, including $4 million of convertible loans, and Radius Ventures will invest $5 million.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Duke University Medical Center Study Suggests Adjusting PSA Scores for Obese Men or Cancers May be Missed  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78188&amp;full=1</link><description>DURHAM, N.C. -- Doctors may be missing cancers in obese men because the telltale blood marker used to detect the disease can be falsely interpreted as low in this population, according to a new study led by Duke Prostate Center researchers."Obese men have more blood circulating throughout their bodies than normal weight men, and as a result, the concentration of prostate-specific antigen, or PSA...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Use of Intraoperative MRI Adds Time But Care-Changing Information To Neurosurgery, Study Shows  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78196&amp;full=1</link><description>Although the use of intraoperative MRI can add time to surgical procedures, it can help surgeons detect residual disease and, if needed, modify their plan for surgery while the patient is on the operating room table, according to a study conducted by researchers at the University Hospitals of Cleveland/Case Western Reserve University in Cleveland, OH and Johns Hopkins University in Baltimore, MD.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Virtual Radiologic Announces Closing of Initial Public Offering and Exercise of Option to Purchase Additional Shares  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78204&amp;full=1</link><description>&lt;p&gt;    MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall/ -- Virtual Radiologic Corporation  today announced the closing of its initial public offering of 4,600,000 shares of common stock at a price to the public of $17.00 per share.  The offering consisted of 4,000,000 shares offered by Virtual Radiologic and an additional 600,000 shares offered by certain selling stockholders pursuant to the exercise by...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Spinal Elements, Inc. Receives FDA 510(k) Market Clearance for its Lucent(R) Spinal Implants as a Lumbar Intervertebral Body Fusion Device (IBFD)  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78198&amp;full=1</link><description>CARLSBAD, Calif.--(BUSINESS WIRE)--Spinal Elements, Inc. announced today the receipt of FDA 510(k) clearance to market the Lucent Spinal Implants as lumbar intervertebral body fusion devices (IBFD). This clearance of the Lucent system enables surgeons to utilize this advanced implant and instrumentation technology for degenerative disc disease and other common spinal maladies.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>FDA Clears Veridex, LLC's Advanced Test for Monitoring Metastatic Colorectal Cancer  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78203&amp;full=1</link><description>&lt;p&gt;Capable of detecting minute numbers of circulating cancer cells in 40 billion blood cells, the CellSearch test can help guide patient care decisions&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;WARREN, N.J., Nov. 20 /PRNewswire-USNewswire/ -- Veridex, LLC today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch(TM) System to be used as an aid in the monitoring of metastatic...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;EarlySense&lt;/b&gt; Receives FDA Clearance for Its Contact-Free Patient's Clinical Status Monitor  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78174&amp;full=1</link><description>RAMAT-GAN, Israel--(BUSINESS WIRE)--EarlySense Ltd., developer of smart systems for monitoring changes in a patients clinical condition, announced today that it has received FDA clearance for its ES-16 system. The ES-16 system, cleared by the FDA, monitors heart and respiratory rates in both children and adults.The technology developed by EarlySense utilizes a proprietary contact-free sensor...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Span-America Medical Systems, Inc. Says Hill-Rom, Inc. Supply Deal to End  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78205&amp;full=1</link><description>GREENVILLE, S.C.--(BUSINESS WIRE)--Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that its exclusive agreement to supply Hill-Rom Company, Inc. with private label support surfaces will expire on May 4, 2008. Following the expiration of the exclusive supply contract, Span-America will be able to sell its proprietary PressureGuardCFT therapeutic support surfaces to non Hill-Rom customers...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Positive Results for s  Cancer Diagnostic Test  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78210&amp;full=1</link><description>Hadasit Bio Holdings Ltd. (TASE:HDST) portfolio company InCure Ltd. reports positive results in the clinical trial for its device, which uses blood samples to diagnose breast and colon cancers.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Bio-Rad Laboratories, Inc. Paper Describes the Effect of RNA Degradation on Data Quality  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78273&amp;full=1</link><description>HERCULES, CA - November 21, 2007  Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the availability of a technical paper (bulletin 5452A) that describes the effect of RNA degradation on data quality in quantitative PCR and microarray experiments. The paper describes using automated...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Medrad, Inc. Mobile MR Injector Meets Challenges of MR Trailers Design of Spectris Solaris(R)  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78228&amp;full=1</link><description>&lt;p&gt;    WARRENDALE, Pa., Nov. 20 /PRNewswire/ -- With the introduction of the Spectris Solaris(R) EP Mobile MR Injection System today, MEDRAD once again addresses the challenges clinicians face in a mobile magnetic resonance (MR) imaging trailer with market-leading injector technology suited for small spaces.&lt;/p&gt;&lt;p&gt;    (Logo:  http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )&lt;/p&gt;&lt;p&gt;    The new...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>CardioMag Imaging, Inc. (CMI) Announces Results of 2006 Annual Shareholders Meeting and Board Meeting  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78227&amp;full=1</link><description>&lt;p&gt;    SCHENECTADY, N.Y., Nov. 20 /PRNewswire/ -- CardioMag Imaging, Inc. (CMI) is pleased to announce that at its Annual Shareholder Meeting held on November 7 2007, Monica R. Brettler, Tush P. Nikollaj, Carl H. Rosner and Arthur Roth were elected to serve as Board members of CardioMag Imaging.  Also approved at the November 7th Annual Shareholders Meeting was the proposal to reduce the number of...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>IntelGenx Technologies Corp. Reports Financial Results for the First Nine Months of 2007  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78298&amp;full=1</link><description>SAINT LAURENT, QUEBEC--(Marketwire - November 21, 2007) - IntelGenx Technologies Corp. (OTCBB: IGXT), a drug delivery company creating novel oral delivery technologies for generic pharmaceutical markets, announced today it has filed its quarterly report ("the report") on Form 10-QSB for the three and nine months ended September 30, 2007. The report, filed with the SEC and the OSC (Ontario Securities...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Haemonetics Corporation Completes Acquisition of TEG(R) Hemostasis Analyzer Business  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78247&amp;full=1</link><description>&lt;p&gt;    BRAINTREE, Mass., Nov. 20 /PRNewswire-FirstCall/ -- Haemonetics Corporation, a global blood management company, confirmed today that it has acquired Haemoscope Corporation's TEG(R) Thrombelastograph(R) Hemostasis Analyzer business for $44 million cash.  The companies previously announced their agreement on the acquisition.  (See press release of October 30, 2007.)&lt;/p&gt;&lt;p&gt;    Chris Lindop, Haemonetics...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Celera Genomics Group-an Applera Corp. Business and Ipsen Enter Research Collaboration to Develop Pharmacogenomic Tests  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78270&amp;full=1</link><description>PARIS &amp; ALAMEDA, Calif.--(BUSINESS WIRE)--Celera (NYSE:CRA), an Applera Corporation business, and Ipsen (Euronext:FR0010259150;IPN) today announced that they have entered into a research collaboration to develop biomarker and pharmacogenomic tests for growth failure patients. The initial phase of the collaboration will focus on the discovery and characterization of genetic markers relating to this...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>GE Healthcare and iCAD, Inc. Enter into Developmental Agreement Partnership  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78278&amp;full=1</link><description>&lt;p&gt;    NASHUA, N.H. and WAUKESHA, Wis., Nov. 21 /PRNewswire-FirstCall/ -- iCAD(R), Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions and GE Healthcare, a division of GE , a manufacturer of Senographe(R) Full-Field Digital Mammography (FFDM) systems, today announced an agreement to develop a customized version of iCAD's SecondLook(R) Digital specific to GE's Senographe...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Bio-Rad Laboratories, Inc. Launches ProteoMiner Protein Enrichment Kits  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78289&amp;full=1</link><description>HERCULES, Calif., November 20, 2007  Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the introduction of its new ProteoMiner protein enrichments kits, which enable researchers to concentrate and enrich low- and medium-abundance proteins that cannot be detected through traditional...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Varian Medical Systems to Introduce Two New PaxScan(R) Flat-Panel Digital Radiography Products at RSNA This Year  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78292&amp;full=1</link><description>&lt;p&gt;    PALO ALTO, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. , a premier supplier of X-ray tubes and the PaxScan(R) line of digital X-ray image detectors, will introduce two new PaxScan products at the annual meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago from November 25 - 30, 2007.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;    Except for their physical size...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>CIBA Vision Corporation, the Eye Care Unit of Novartis International AG, Announces Settlement of Patent Litigation with  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78294&amp;full=1</link><description>Duluth, Georgia, November 21, 2007 - CIBA Vision, the eye care unit of Novartis, has reached a final global patent litigation settlement agreement with CooperVision, Inc. (NYSE: COO) that resolves all current patent infringement lawsuits between the two companies. </description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Bioject Medical Technologies Inc. Announces Convertible Debt Financing  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78286&amp;full=1</link><description>PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Nasdaq:BJCT), a leading developer of needle-free injection therapy systems, today announced it has entered into convertible debt financing with Mr. Ed Flynn, a private investor, who will be rejoining the Board of Directors. In addition to the funding provided by Mr. Flynn, Biojects CEO and other executive officers and a member of...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Astro-Med, Inc. Reports Record Sales in Third Quarter; Directors Declare Regular Dividend  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78297&amp;full=1</link><description>Astro-Med, Inc. (NASDAQ: ALOT) reports record sales for the Third Quarter of $19,139,000, representing an increase of 19% over the $16,043,000 achieved in the Third Quarter of the prior fiscal year. Third Quarter bookings amounted to a record $21,000,000. </description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Masimo Corporation Receives a Frost &amp; Sullivan 2007 Industry Best Practices Award  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78242&amp;full=1</link><description>&lt;p&gt;    IRVINE, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Masimo , the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry, announced it has received a Frost &amp; Sullivan 2007 Industry Best Practices Award, for Pulse Oximetry Leadership -- "ranking number one in the pulse oximetry industry." Frost &amp; Sullivan further recognized "the impressive progression of Signal Extraction...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Bio-Rad Laboratories, Inc. to Sponsor Webinar on Reproducibility Issues In Protein Biomarker Research  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78274&amp;full=1</link><description>HERCULES, CA  November 21, 2007  Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it is sponsoring and hosting a free Science magazine webinar that will discuss reproducibility issues in mass spectrometry-based biomarker discovery.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>CLX Investment Company Announces Successful Attendance at - 39th World Forum for Medicine International Trade Fair  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78295&amp;full=1</link><description>CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that CEO Vera Leonard and other company representatives have successfully completed their attendance at MEDICA, the world's largest medical trade fair, which was held November 14-17, 2007 in Dusseldorf, Germany...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Wright Medical Group, Inc. to Participate in the 19th Annual Piper Jaffray Health Care Conference  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78285&amp;full=1</link><description>ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced today that it will be participating in the 19th Annual Piper Jaffray Health Care Conference on Tuesday, November 27, 2007 at the Pierre Hotel in New York City. Gary D. Henley, Wrights President and Chief Executive Officer, will present at 8:00 a.m. Eastern Time.</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Boston Scientific Corporation to Participate in Health Care Conference  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78291&amp;full=1</link><description>&lt;p&gt;    NATICK, Mass., Nov. 21 /PRNewswire-FirstCall/ -- Boston Scientific Corporation  is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held November 27 - 29 in New York City.&lt;/p&gt;&lt;p&gt;    Paul LaViolette, Chief Operating Officer, will make a 30-minute presentation on Wednesday, November 28th, beginning at approximately 9:00 a.m. E.T.&lt;/p&gt;&lt;p&gt;    A live webcast of...</description><pubDate>Wed, 21 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Smith &amp; Nephew Endoscopy  Announces the Sale of its Vascular Business  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78039&amp;full=1</link><description>&lt;p&gt;    ANDOVER, Mass., Nov. 19 /PRNewswire-FirstCall/ -- Smith &amp; Nephew's   Endoscopy Division today announced the sale of its vascular business to InaVein LLC, a Boston-area investor group led by Jonathan Donaldson and Patrick Maley, longstanding members of the medical device marketplace. Terms of the sale were not disclosed.&lt;/p&gt;&lt;p&gt;    The sale supports Endoscopy's objective to refine its product...</description><pubDate>Tue, 20 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Public Never Warned About Dangerous Device  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78031&amp;full=1</link><description>A young mother in Los Angeles was desperate. A rare form of cancer was ravaging her 5-month-old son. Their doctor said chemotherapy offered the best hope for survival, a 1-in-4 chance.Natalia Campos watched as her baby, Antonio, struggled in pain through the first few treatments. Then she learned of an alternative-therapy clinic that promised a cure, without pain, using a machine called a PAP...</description><pubDate>Tue, 20 Nov 2007 12:00:00 AM GMT</pubDate></item><item><title>Broncus Technologies, Inc. Files for IPO of Up to $86.3 Million  </title><link>http://www.devicespace.com/news_story.aspx?StoryID=78035&amp;full=1</link><description>MOUNTAIN VIEW, CA--(Marketwire - November 20, 2007) - Broncus Technologies, Inc., a medical technology company focused on developing and commercializing minimally invasive medical devices for emphysema and other lung diseases, today announced the filing of a registration statement with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. All...</description><pubDate>Tue, 20 Nov 2007 12:00:00 AM GMT</pubDate></item></channel></rss>